Drug packaging – the principal diversities between the EU and America to know

Packaging has to meet a list of goals, such as: conserve the product, prevent theft, be cheap, and uphold a balance among its performance and its cost, both from the point of view of the material employed and the time involved to make the packing.

From an ecological perspective, it is important that materials are quickly recycled and employed as little as possible.
There are various products in the retail that may be confused with one other by cause of identical aspects, colors or trademarks. Drug packaging should differ significantly from hygiene and cooking products. For example, American tablet packaging confounds a medicine with a snack, and this is not a good idea… for the buyer. Packaging for human drugs is one of the major fields of design and research. And it would be good to take into consideration that, in this matter, there are evident diversities between the EU and the USA. While health in the United States is a topic of privates and insurance economic issues, in most countries in Europe it is governmental. This difference modifies the manner in which drugs are seen by the public. Thus, American drugstores offer a wide range of medicines with a graphic design that in the EU is usual of mostly alimentary supplements.

On the other hand, in Europe, where the promoting of medications is much more severe, the tablet packaging tends to fave a more sober appearance, with nothing fancy and no suggestions. The reason for this difference in marketing communications is simple: the package’s target in the EU are doctors, while in the most of the US, the target of the package is the patient.